Form 4 for BIVI BIOVIE INC.
Accepted 2023-07-03 00:00:00 ET · period of report 2023-06-29 · accession 0001520138-23-000275 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2023-07-03 | 2023-06-29 | BIVI | DO CUONG V | CEO, Pres, Dir | A - Grant | $0.00 | +149.5K | 425.9K | +54% | $0 |
| DI | 2023-07-03 | 2023-06-29 | BIVI | DO CUONG V | CEO, Pres, Dir | A - Grant | $0.00 | +175.0K | 175.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-29 | A | A | 149,500 | $0.00 | 425,854 | I See Footnote | — | — | (F2) Securities are held in the name of Do & Rickles Investments LLC. |
| 2 | Derivative | Stock Option (right to buy) | 2023-06-29 | A | A | 175,000 | $0.00 | 175,000 | I See Footnote | $4.10 · — to 2033-06-28 | 175,000 Common Stock | (F2) Securities are held in the name of Do & Rickles Investments LLC. (F1) The options vest in three equal annual installments beginning on June 29, 2024 (the first anniversary of the grant date). |